Education
About Us
Working with TipRanks
Follow Us
Clarivate (CLVT)
NYSE:CLVT
CLVT Stock Chart & Stats
$2.52
-$0.17(-3.38%)
At close: 4:00 PM EST
$2.52
-$0.17(-3.38%)
Day’s Range― - ―
52-Week Range$1.66 - $4.77
Previous CloseN/A
Volume814.08K
Average Volume (3M)5.54M
Market Cap
$1.61B
Enterprise Value$5.82B
Total Cash (Recent Filing)$329.20M
Total Debt (Recent Filing)$4.48B
Price to Earnings (P/E)176.2
Beta0.98
Next Earnings
May 12, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding640,698,600
10 Day Avg. Volume6,775,614
30 Day Avg. Volume5,535,747
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.46
Price to Sales (P/S)0.92
P/FCF Ratio6.16
Enterprise Value/Market Cap3.61
Enterprise Value/Revenue2.37
Enterprise Value/Gross Profit3.59
Enterprise Value/Ebitda7.03
Forecast
1Y Price Target
$3.38Price Target Upside34.13% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)0.73
Revenue Forecast (FY)$2.36B
Bulls Say, Bears Say
Bulls Say
Business StrategyCLVT has restructured its business model to focus on recurring revenue streams, which is expected to provide more stability in revenue.
Financial GuidanceManagement raised full-year revenue guidance due to improved organic growth outlook and favorable FX rates.
Revenue PerformanceClarivate's third-quarter revenue exceeded estimates by $53 million, driven by higher-than-expected transactional revenues.
Bears Say
Growth RisksThe largest risks to CLVT's growth prospect include AI disintermediation, high leverage, and execution on its value creation plan.
ProfitabilityAdjusted EBITDA margin fell short of the model by 140 basis points.
Revenue StabilityRecurring revenue fell short, coming in 70 basis points below the model.
Clarivate News
CLVT FAQ
What was Clarivate’s price range in the past 12 months?
Clarivate lowest stock price was $1.66 and its highest was $4.77 in the past 12 months.
What is Clarivate’s market cap?
Clarivate’s market cap is $1.61B.
When is Clarivate’s upcoming earnings report date?
Clarivate’s upcoming earnings report date is May 12, 2026 which is in 67 days.
How were Clarivate’s earnings last quarter?
Clarivate released its earnings results on Feb 24, 2026. The company reported $0.2 earnings per share for the quarter, beating the consensus estimate of $0.164 by $0.036.
Is Clarivate overvalued?
According to Wall Street analysts Clarivate’s price is currently Undervalued.
Does Clarivate pay dividends?
Clarivate does not currently pay dividends.
What is Clarivate’s EPS estimate?
Clarivate’s EPS estimate is 0.15.
How many shares outstanding does Clarivate have?
Clarivate has 640,698,600 shares outstanding.
What happened to Clarivate’s price movement after its last earnings report?
Clarivate reported an EPS of $0.2 in its last earnings report, beating expectations of $0.164. Following the earnings report the stock price went up 39.881%.
Which hedge fund is a major shareholder of Clarivate?
Currently, no hedge funds are holding shares in CLVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.38 (34.13% Upside)
$3.38 (34.13% Upside)
Blogger Sentiment
Bullish
CLVT Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 15.8M Shares
Last Quarter.
Last Quarter.
News Sentiment
Bearish
Bullish news 33%
Bearish news 67%
Bearish news 67%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.73%
12-Months-Change
Fundamentals
Return on Equity
-7.60%
Trailing 12-Months
Asset Growth
-6.67%
Trailing 12-Months
Company Description
Clarivate
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
CLVT Company Deck
CLVT Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful operational progress and clear positive momentum: the company hit its full-year guidance, improved recurring revenue mix and ACV trends, delivered >$1 billion adjusted EBITDA and $365 million of free cash flow, and outlined optimistic 2026 guidance (2-3% ACV growth, ~10% FCF growth). Management emphasized AI-driven product innovation and adoption (multiple product launches and user adoption metrics) and initiated a strategic review of the portfolio with a potential LS&H sale to accelerate value creation. Offsetting these positives are near-term top-line pressures from disposals and transactional wind-downs (expected revenue decline ~ $100M midpoint in 2026), modest organic revenue growth (flat overall), higher near-term operating expense/investment, and a multi-year turnaround required in parts of IP. On balance, the positives (cash generation, margin expansion potential, AI/product traction, and concrete capital-deployment actions) outweigh the negatives, supporting an optimistic outlook.View all CLVT earnings summariesCLVT Stock 12 Month Forecast
Average Price Target
$3.38
▲(34.13% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---